[Biomaterials and public health: avoid the drift].
The difficulties found in the maturation of the Science of Biomaterials are analysed at the different levels: research, education, industry, reglementary and legislative environment, needs of hospitals and private practices. Proposals are made for a better response to the needs of an area which should have a growth at least as important as that of drugs.
Muster
D
D
LEED Biomatériaux, CHRU, Strasbourg.
Le Borgne
E
E
D001672:Biocompatible Materials / Q000737:chemistry / Q000145:classification / Q000592:standards; D004493:Education; D004865:Equipment and Supplies, Hospital; D005060:Europe; D006801:Humans; D007221:Industry; D008422:Materials Testing; D004364:Pharmaceutical Preparations; D011331:Private Practice; D011634:Public Health; D012106:Research; D013672:Technology / Q000331:legislation & jurisprudence; D014481:United States; D014486:United States Food and Drug Administration
D001672:Biocompatible Materials; D004364:Pharmaceutical Preparations
Biomatériaux et santé publique: éviter la dérive.